Muscle Parameters and Pathological Response in Breast Cancer Patients
The Relation Between the Initial Value of the Skeletal Mass Index and Pathological Response
Sponsor: Acıbadem Atunizade Hospital
Listed as NCT06151379, this observational or N/A phase trial focuses on Neoadjuvant Chemotherapy and remains completed. Sponsored by Acıbadem Atunizade Hospital, it has been updated 4 times since 2023, reflecting limited change activity. This study adds to the evidence base for this therapeutic area through structured, versioned documentation.
Status Flow
Change History
4 versions recorded-
Sep 2025 — Present [monthly]
Completed
-
Sep 2024 — Sep 2025 [monthly]
Completed
-
Jul 2024 — Sep 2024 [monthly]
Completed
-
Dec 2023 — Jul 2024 [monthly]
Completed
First recorded
Mar 2023
Trial started
Per CT.gov start date — pre-dates our first snapshot
Eligibility Summary
No eligibility information available.
Contact Information
- Acıbadem Atunizade Hospital
For direct contact, visit the study record on ClinicalTrials.gov .